Microbix Biosystems (TSE:MBX) Shares Pass Above Fifty Day Moving Average – Should You Sell?

Microbix Biosystems Inc. (TSE:MBX) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$0.41 and traded as high as C$0.50. Microbix Biosystems shares last traded at C$0.50, with a volume of 51,373 shares traded.

Microbix Biosystems Stock Performance

The business has a 50-day moving average of C$0.41 and a two-hundred day moving average of C$0.36. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57. The company has a market cap of C$67.67 million, a P/E ratio of 12.38 and a beta of 0.34.

Insider Activity

In other news, Director Bo Hollas sold 150,000 shares of the business’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total transaction of C$73,500.00. Also, Director Cameron Lionel Groome sold 200,000 shares of the company’s stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of C$0.43, for a total transaction of C$86,500.00. In the last ninety days, insiders have sold 400,000 shares of company stock worth $181,000. Corporate insiders own 14.00% of the company’s stock.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.